Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Endometrial Neoplasms × liposomal doxorubicin × Clear all

Sponsor

Conditions

Ovarian Neoplasms 27 Breast Neoplasms 19 Fallopian Tube Neoplasms 18 Multiple Myeloma 14 Carcinoma, Ovarian Epithelial 12 Lymphoma 7 Triple Negative Breast Neoplasms 4 Neoplasms, Plasma Cell 3 Prostatic Neoplasms 2 Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Large B-Cell, Diffuse 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Subcutaneous panniculitis-like T-cell lymphoma 1 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma, Kaposi 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Peritoneal Neoplasms 1 Patient Participation 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1

Interventions

pembrolizumab 14 Paclitaxel 14 Carboplatin 10 Bevacizumab 6 rucaparib 5 lenvatinib 5 Megestrol Acetate 5 Radiation 4 Nivolumab 4 Indocyanine Green 4 tisotumab vedotin 3 temsirolimus 3 Sirolimus 3 Sentinel Lymph Node Biopsy 3 Doxorubicin 3 olaparib 2 ixabepilone 2 iso-sulfan blue 2 irosustat 2 epacadostat 2 durvalumab 2 copanlisib 2 Taxes 2 Metformin 2 Magnetic Resonance Spectroscopy 2 Letrozole 2 Ipilimumab 2 Gemcitabine 2 Fulvestrant 2 Cisplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡